Posts tagged with: Fujifilm

Pandemics End?

This article, edited, appeared in The American Thinker on May 16th, 2023

Several weeks ago, on my way to lunch, I stopped at the testing facility in our hospital for my weekly COVID test. This has been a requirement of my employment for at least the last year and a half after I refused vaccination.  The pretty young woman that has been assisting me, collected my sample. She then informed me that the testing facility was closing for good later today.  Subsequently, the hospital administration minimized the requirements for masking within the facility. With these developments, it felt as though the COVID debacle had finally ended.

Reflecting on this, I think back over the 3+ years and cannot escape the profound effect it has had on my life both during the pandemic and now afterward. I have seen death, certainly particularly in older patients and those with comorbid problems. But I have also seen fear and anxiety as a catalyst of social change, and generally not for the good. I have seen factionalism develop over differences in one’s level of vigilance and concern over the disease burden, and later about attitudes towards treatment and vaccination.

I lost friendships. In the beginning it was over the fear of being in contact with me as a caregiver for these patients. Later it was because I invoked natural immunity, and avoided vaccination. I endured their ridicule and even anger about my quaint notions of viral immunity, ideas that would have seemed completely rational, 2 years before.

Now things are changing. Very quietly I think people have grown to accept the notion that this virus was born in the Wuhan lab. It became clear that the draconian lockdowns were of little help, and left a lot of economic, social, and educational damage. They are finally beginning to understand that natural immunity, though not perfect, is likely to be more durable than that provoked by “boosters”.

It is also beginning to sink in, that the vaccines, were untested, minimally helpful and are likely to an extent unsafe, especially for the young. The lack of acceptance of the new bivalent injection I think confirms a new public wariness. Likewise, there has been a pronounced lack of enthusiasm for pediatric inoculation.

But for me, there have been much broader revelations.

As a physician in my 40th year of practice, the events of the past several years have had a profound effect on the way I think of the care I have been rendering.

The CDC, and NIH, manipulated the government, and the willing press, into supporting incredibly corrupt behavior. Prestigious medical journals, such as the Lancet, suspended their usual stringent review processes to publish fraudulent data. The regulatory agencies, and Pharma, acting in concert, punished non-doctrinaire opinions. They manipulated our academic institutions by the issuance and withholding of grant money. Leaders such as the beloved Dr. Fauci promoted phony letters to the editor decrying the lab leak origin story. This was done to protect the NIH and its likely illegal contributions to the Wuhan Institute of Virology for gain-of-function research.

Because of all of this, I looked back and wondered about my entire career. Was everything a lie? Were there medications, perfectly adequate, that I was convinced to discontinue in favor of new patented and expensive medications, with less well-understood safety profiles? How many of the other articles that I had read over the years were corrupt documents, meant to bolster the profits of the pharmaceutical industry? Just how badly have I been manipulated?

As a physician, particularly at my age, I have tried hard to remain current with my specialty. But how much of the latest information I absorbed served only to support the lucrative relationship between academic medicine and their sponsors at the pharmaceutical companies.

I never meant to bring too much drama to this pandemic, which I was fairly sure, even early on, would not be as severe as the doomsayers predicted. But I failed to anticipate the more profound interpersonal, economic, and professional impacts it would have on my life and that of others.

There is a punch line here. Despite being completely asymptomatic, and despite the fact, that months ago, the CDC declared random testing to be useless my last test was… positive.

Feels like a fitting end for this nonsense…at least for now.

I would be honored if you shared this.

Header image: After the Fire (Fujifilm X100V)

Viral post, December 23, 2021: My Omicron Infection

It is been a year and 11 months since the happy little packet of spike proteins and mRNA arrived in our country courtesy of Dr. Fauci and the Chinese Communist Party.

So here’s a little schadenfreude for my naysayers: yesterday, I was diagnosed with what I suspect is Omicron. In my case, it started with very subtle bronchitic symptoms at the end of the day on Tuesday. Walking out to my car from work, I suddenly felt an unexpected sense of fatigue for that time of day. Suspicious, I went straight home, and grabbed a home test kit. That first test was negative.

Overnight I felt chilled and achy but took some Naprosyn which improved my symptoms. The next morning I retested and was unequivocally positive.

Since then, my main symptoms have been that of a rather annoying viral respiratory infection. There is some fatigue, a modest cough, but a lot of upper respiratory congestion and sneezing. Yesterday, at least in the morning, the symptoms might have prompted me to call off work (as if I weren’t busy) even without the quarantine requirements of Covid-19. Today I feel better. Symptomatically I would’ve gone back to work, albeit with a little self-pity.

Unfortunately, this is SARS CO-V2. The 10 day period of isolation will encompass Christmas, and disrupt plans to gather with family, and otherwise socialize. This arbitrary number is annoying given that I can easily retest when I become asymptomatic and prove I’m not shedding virus.

In my case, I can see why this variant spreads so efficiently. Omicron infects preferentially the tracheobronchial tree, versus the alveoli (lung tissue) in earlier viruses. It thus causes more cough and sneezing symptoms which help to aerosolize and spread the viral particles. Given this, however, it is much less likely to cause issues with “gas exchange” and thus hypoxia and respiratory failure. This seems to have so far borne out both in South Africa and now Great Britain.

I have been taking again the cocktail of hydroxychloroquine, and azithromycin, given the unavailability of Ivermectin. I’m also taking zinc, vitamin D, and a B complex supplement in addition to my usual medications.

Obviously, my situation will not be universal, and some people, particularly people with lung disease, will have more problems. But in reading reports in countries where omicron has become dominant, this is a fairly typical presentation. From my point of view my experience is nothing to get excited about. We’ll see what happens but, three years ago, if such an illness were spread in the community, I would probably notice an increase in exacerbations in my asthma and COPD patients. I have seen this kind of outbreak many times before Covid. The general public is typically unaware.

Omicron has definitely changed the game. There is an international study in preprint, detailing the mutational change in the virus, and its ability to escape immunity, both natural, and vaccine-induced. Here is an article in Forbes that nicely summarizes the study’s findings. In short, the spike proteins have mutated to cling more tightly to the ACE-2 receptors in the respiratory tree, which may explain the preference for the upper airways. Natural immunity also has been thwarted by these new mutations. This was studied by using convalescent serum.

It is interesting to look at the vaccines in detail. Pretty much all of the vaccines lost efficacy against the virus two weeks after the last injection. By three months post the third injection, the vaccinated were susceptible to Omicron. It is interesting to me that the most durable vaccine appears to of been the one offered in China by Sinopharm, which, by the way, is a traditional attenuated live viral vaccine. This means people are vaccinated against the whole virus, rather than just the spike protein.

Parenthetically, according to Robert Malone, the inventor of the mRNA vaccine technique, traditional vaccines take much longer to produce. China appears to have gotten it done in record time. I wonder whether they had a “head start”

To me, all of this suggests several conclusions:

#1. With Omicron we are essentially back to square one in terms of immunity. Thank God it isn’t particularly virulent. Hopefully, this will be a trend.

#2. As with multiple efforts with coronaviruses in the past, vaccination is not a practical solution, and ought to be deemphasized.

#3. It’s time to turn to therapeutics, which are less likely to be affected by mutations.  We need Ivermectin to be freed up for use. The promising new antiviral from Pfizer, Paxlovid, has just been granted an Emergency Use Authorization but is unlikely to be widely available for some time. Unfortunately, from their own data, Merck’s drug Molnupivinir, may not be particularly useful.

As I have said before, this virus and its variants are becoming endemic in the population. Any expectation that you will not be infected, or re-infected, is likely unrealistic.

And for my vaccine-devoted, Fauci-worshiping critics, enjoy your opportunity to revel in my illness.

Your turn is coming.

As always, I’d be honored if you’d share.

Header Image: Tracks on the Back Pond (Fujifilm X Pro 1, XF 18-55mm f2.8-4)

Viral Post November 27, 2021: Covid Info is Changing Fast

It has been 21 months of social upheaval and weirdness since the gift of love from the NIH and the Wuhan Institute of Virology.  In that time period, we have seen a widespread loss of faith in our government health apparatus based on contradictory, illogical, and frankly nefarious behavior.

I’ve divided this article into two parts:

Part number one was intended to be published on 18 November, but frankly, for a variety of reasons, including sloth, I didn’t get around to it.

Part two is being written today. I’m doing this in part because of new developments that are significant, and also as a bit of “I told you so”.

Part one: November 18

Overall U.S. Covid “cases” are falling, particularly in the South, while some isolated northern states are having surges.  We have seen this seasonal pattern before, with the arrival of the outdoor recreation season in some climates, while others seek shelter as temperatures drop.

If you look at recent data, the percentage of hospitalizations and death, as a percentage of the total “cases” has also been falling. This is likely due to multiple factors, including vaccination, increasing natural immunity, and better care particularly in the ICUs.  It may also be due in part to the more benign characteristics of the current “delta” variant which is now dominant in the population.

A virus can be thought of as a small biological machine.  They are not considered as living entities, but more as mechanisms.  The spread and dominance of variants tend to occur when mutations cause a particular set of useful characteristics:

1.  The virus evolves to be more infectious.  This could mean that smaller numbers of viruses are needed to institute an infection, and/or the virus changes characteristics to survive better between hosts.  The virus can also evolve to create symptoms in the host that facilitate spread, such as coughing or diarrhea.

2.  The virus becomes less lethal.  These little mechanisms derive no benefit from killing their host.  Arguably the virus can spread more rapidly if the symptoms are mild, and the host remains in contact with others.  Decreasing lethality will also be caused by an increase in acquired immunity in the population (and perhaps their offspring).  In other words, we and the virus evolve so that we can coexist.

Other than the outlier viruses SARS CoV, MERS Co-V, and SARS-CoV2, there have been four coronavirus types that typically circulate in the population and cause respiratory infections.  These typically cause mild to moderate symptoms though they too can be the cause of pneumonia, and ultimately death, in vulnerable populations.    They are estimated to be responsible for 10 to 30% of viral respiratory infections.

Now here’s the thing. Because they are generally benign, and there has been no therapy identified specifically for these viruses, we generally do not test for them.  And we certainly do not isolate or vaccinate. But we do for Covid.  And at some point, that is going to have to change.

Coronaviruses in general have been endemic in the human population for thousands and thousands of years.  Acquired immunity to them tends to be “relative” in that people tend to be reinfected multiple times in their lives, but typically with modest symptoms.

That may explain the performance of the current vaccines.  At this point, they do not seem to prevent infection and spread but do seem to blunt the severity of the illness that results (though this effect is also waning).  The point is, that SARS-CoV2, will likely become an endemic virus, and any expectation that you will not be reinfected at some point is probably unrealistic.  At some point, we will need to normalize our behavior towards this infection and cease with all the isolation and dramatics.

There is some hope.  As much as I despise Pharma, and their actions regarding hydroxychloroquine and Ivermectin, Merck, and now Pfizer, have introduced oral medications for Covid.  Happily, these drugs are patented, so the pharmaceutical companies will make a lot of money and so happily promote their use.

 Pfizer claims that their medication Paclovid, reduced hospitalization by 89% and death by 100% in their clinical trials.  If this bears out, it would definitely be a significant development, with the potential to change both the epidemiology and psychology of this illness.  Merck claims that their new medication Molnupiravir, was roughly 50/100% effective using the same criteria.

In case you wondered, in several meta-analyses, Ivermectin is about 65% for early treatment, with similar numbers for late treatment. It’s about 87% effective for prophylaxis.

I wonder, given these new medications, and the growing sense that the vaccines seem both relatively risky and ineffective, that Pharma will deemphasize the “jabs” for their new therapeutics.  This may be especially true now that monoclonal antibody cocktails given subcutaneously, have recently been shown to have potential as COVID-19 prophylaxis for as long as eight months.

Part two:

So that was written on November 15-17. It is now 2 weeks later and there have been significant developments since.

The number one development would be the continual deterioration in vaccine performance. We are now seeing significant numbers of fully vaccinated people admitted to ICUs, in some cases never discharged. Both director Walinsky, and Dr. Fauci have been forced to acknowledge this. Their answer: inject patients with even more spike protein mRNA.

There is an abstract published in the Journal Circulation that studied the body’s release of certain biomarkers predictive of cardiac complications after receiving the mRNA vaccine. It concluded:  “that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.”

Now, remember back in 1998. A paper was published by one study group investigating the effect of hormone replacement therapy for postmenopausal females on the heart. It concluded surprisingly, that cardiac outcomes were worse in females who were receiving HRT. In an instant, HRT ceased as an option for women.

Let’s see whether this Circulation article has a similar effect on these vaccines (I doubt it).

Poor Merck. They spent the last year impugning their old drug Ivermectin for the treatment of Covid 19. Shockingly they then released their new oral therapeutic, Molnupiravir which they initially reported as having a 50% reduction in illness and death when used treatment of SARs-CoV2. This made Dr. Fauci very excited.

Fun fact: Molnupiravir works by inserting errors into the viral genetic code. Apparently, during the trials, subjects were required to refrain from heterosexual sexual intercourse, and in the case of females, be using birth control. What could go wrong?

Earlier this week they downgraded that effectiveness number to roughly 30%. This is a problem when Pfizer is reporting 89% effectiveness of their new oral medication Paclovid. If this data bears out I would imagine Molnupiravir will be a bust. Karma is a bitch.

Just so you know, the geniuses in our government have already arranged to buy $1.7 billion worth of this apparent loser. Oops.

  By the way, the much more effective Pfizer drug uses a similar mechanism of action to… You guessed it… Ivermectin.

And now we have the Omicron variant emerging from South Africa. This apparently has the World Health Organization in a tizzy, which the press is dutifully reporting. This variant is said to carry multiple mutations including changes to the spike protein (you know, where the vaccines work). It is said to be more infectious than Delta, but there are indications that symptoms are generally mild. There is obviously great hand wringing that it will be vaccine-resistant (like delta already is?).

Maybe they can lock us down again this Christmas.

To close this up, let me review the facts we need to remember to avoid being manipulated by the hype.

  1. SARs-CoV2 is a respiratory virus, much less severe than SARs1, and over time, roughly as deadly as a bad influenza season.
  2. We are being pushed to take multiple doses of hastily developed, still investigational monovalent vaccines. We are vaccinating during a pandemic which generally a bad idea. The vaccines over time do not really appear to be very effective.
  3. The new variant is  likely doing what viruses are supposed to do; evolving to become more infectious but less virulent. It is frightening to the medical establishment, because its spike protein mutations threaten to completely discredit their entrenched “vaccine only “policies.
  4. Given the large percentage the population with pre-existing Coronavirus exposure, and ongoing SARs-CoV2 infections, there is likely a high percentage of the population with broad-based immunity, even to new variants.
  5. There are effective IV and now oral medications. Some are repurposed, but there is a new oral med they may actually allow us to use to treat this infection when it occurs.

I apologize for the length of this. I confess that writing these articles helps me to disperse the toxic degree of cognitive dissonance I experience when ingesting Covid information from the government and the media.

I very much appreciate your interest, your shares, and your comments.

Header image: Deer Camp near Sullivan Falls (Fujifilm X-T10, XF 18-55mm f2.8-4)

Viral Post, October 26, 2021: A Tapestry of Deceits

It is been a year and 7 months since a viral pandemic exposed the craven liars who are in charge of our public health organizations, their absolute fealty to “Big Pharma” and disregard for the welfare of the common man. 

The indoctrination of the citizenry into fear of a viral respiratory infection has been accomplished through a supplicant news media.  The more weak-minded individuals who are their acolytes, are now in conflict with more skeptical folks, who notice the discrepancies in what they’re being told, and refuse to submit.  I guess at this point, I stand with the latter group.

I am absolutely infuriated over the draconian vaccine mandates imposed by the current administration.  Both Anthony Fauci, and CDC head Dr. Rachel Walinsky have publicly stated that the vaccine does not prevent spread.  In multiple reports, viral titers in vaccinated patients with recurrence, are as high as, or higher than those of unvaccinated patients.  As I have stated multiple times, the value of the vaccine is to reduce the severity of your illness, which may get you safely through a Covid infection, towards much more potent natural immunity.

Over the last several weeks, I have been touched by this in my personal life.  The small community where I live has a social organization and a fairly lively schedule of events.  One of my favorites is a dinner that occurs in early October, which serves as a fundraiser.  Typically, my wife and I will invite 3 other couples to join us, filling a table.  The event could not occur last year, and we were excited to see it return.

Unfortunately, when the invitation came out, it was accompanied by a new rule: Vaccinated only.

Now people involved with this dinner, read my articles.  They are aware that I have been infected and thus have not been vaccinated (my wife who was never infected, has had her two inoculations).

So, my group and I were not invited.  I know some others in the community who, based on this rule, were also excluded.  A couple of days ago, the dinner, apparently not a draw this year, was canceled.  What is sad is that, given the failure of the vaccine to prevent spread, making it mandatory for the event was useless and counterproductive.

The problem is you can’t reason with people.  When I am in the Adirondacks, I enjoy stopping into a small private club in town.  I was there a couple of weeks ago and stopped off only to find a sign on the front door, with a “vaccination only” message”.  I was told that the Board of Directors had decided on this policy.  Later in the week, I encountered one of the board members (a pretty nice guy by the way).  I made the argument above, which I think frustrated him.  He finally ended the discussion by saying: “We had to do something about Covid!”. 

There you go.  I moved on to another topic.

Dr. Fauci is really in need of retirement (and indictment?) at this point.  His arrogance and his blatant dishonesty are constantly on display in the media.  He was recently asked by Margaret Brennan, moderator of “Face the Nation”, whether we can “gather for Christmas, or it is just too soon to tell?’  Now this is a stupid question on a lot of levels.  His reflexive answer was “it’s just too soon to tell”.   This to me speaks volumes about the control these people believe they should have on our behavior.  Now in fairness, he has backpeddled rather aggressively after a nasty response on social media, but for a minute we caught a glimpse of his mindset.

A much more infuriating comment was made in an interview with Dr. Sanjay Gupta at CNN. Fauci was asked a question, referencing recent data out of Israel suggesting that natural immunity is much more potent than that induced by the vaccination.  He responded: “I don’t have a really firm answer for you on that” he went on to question the durability of natural immunity versus that from “the jab”.

This is literally unbelievable.  This is a man who is in charge of all responses to Covid.  He would, or at least should have knowledge of the published material on this topic.  No really firm answer?  If that is not a deliberate lie, then he is incompetent.

  The CDC estimates there are likely as many as 120 million people that have recovered from Covid.  These people deserve a well-reasoned answer to the question of whether to be vaccinated.  Given the amazing amount of data, from well-designed well-controlled studies that consistently show more complete and durable immunity can be achieved naturally, one is definitely available.  He is undoubtedly the reason why, the NIH and CDC recommend post-infection vaccination even though there is a large increase in adverse effects, many serious, in this group.

I do think the vultures are circling for the good doctor. First, Francis Collins, Fauci’s boss and the longtime head of the NIH resigned. Then the NIH releases a letter to the House Committee on Oversight and Reform, essentially admitting to the fact that indeed they funded indirectly, gain-of-function research on bat viruses in the Wuhan lab. This directly contradicts testimony given under oath by both Fauci and Collins.  Here’s the story, from that notorious right-wing publication Vanity Fair.

Finally, there is the topic of molnupiravir, Merck’s new antiviral currently in trials for the treatment of Covid 19.  In a preliminary study of 385 early Covid patients (vs 377 placebo), it dropped hospitalization rates from roughly 14 to roughly 7% credited as a 50% improvement.  The tablet, which is said to cost $70 a tablet, and was given as 4 tablets, twice a day for 5 days.

Enter Dr. Fauci again.  After the results of a single Merck-sponsored study, he proclaimed: “the results of the trial that were just announced yesterday and the day before are really quite impressive”.  Think back now to spring 2020, and his skepticism of promising early results on cheap and readily available hydroxychloroquine.  Not much difference in the quality of data but a big difference in his enthusiasm.

Of course, there is Merck’s old off-patent drug Ivermectin, or in CNN usage book: “horse dewormer”.

A recent meta-analysis in the American Journal of Therapeutics rigorously evaluated the 60 or so available Ivermectin papers and ended up screening down to 24 randomized control trials, looking at mortality as an outcome.  On average the studies showed a 62% decrease in mortality for ivermectin versus placebo.  There were also improved severity outcomes also though they were not a primary endpoint.  What was the reaction from Dr. Fauci… crickets?

 The cost of Ivermectin?  The drug is somewhat in demand now and has gotten more expensive.  I looked on GoodRx and found that the standard course for treatment of Covid costs between $29 and $60 depending on the pharmacy, and whether you had coupons. In developing countries, the cost of a course is under 2 dollars

Here’s the best part. The government has committed to purchasing $1.7 billion of molnupiravir, should it get past the FDA. This is after spending billions more on its development. This was done despite the fact that we have a cheap, safe, repurposed drug that appears to be just as if not more efficacious.

It should be clear now, that this tapestry of lies woven by public health officials, Pharma, our elected officials, and the press, is rather obviously unraveling:

The vaccines are not really vaccines, and they don’t prevent spread. At best, they function as marginally effective therapeutics.

 Our monovalent (one protein) vaccines are likely facilitating the emergence of new variants.                                                                                                                                                                             SARS-CoV-2 was a product of gain-of-function research at the Wuhan Lab and was funded illegally, by the NIH/NIAID.

Federal and state governments continue to impose draconian vaccine mandates, despite the fact that they are useless, likely unconstitutional, and immoral.

And perhaps worst of all Big Pharma used its extraordinary influence to suppress cheap, effective therapy for this pandemic, costing likely hundreds of thousands of lives for the sake of profit.

What scares me the most is that as a society, I don’t know whether we will ever have enough insight, and integrity, to sort through all of this, and to punish those who are responsible.

If not, God help us.

As usual, I’d be honored if you’d share this post

Header image : Fisherman on Black Pond (Fujifilm XE3, XF 18-55mm f2.8-4)

Eight months with the Fujifilm X100V

Daffodil in Snow
Daffodil in Snow (Fujifilm X100V)

Once upon a time, this used to be a photography site. The site’s camera-related content, particularly related to Fujifilm gear, continues to be the most viewed content over time. Since March, however, I have been distracted by this trivial little virus problem which the articles on the site reflect.  I have now recovered from my own bout of COVID 19. It’s a good time to return to the site’s origins…

 In this case, to discuss my eight-month experience with the Fujifilm X100 V.

Spring Evening at Lake Francis (Fujifilm X100V)

As I wrote at the time, I acquired the camera in March, too late for the last dwindling period of normalcy before the restrictions ruined St. Patrick’s Day, as well as other public and private events I love to cover. Spring blended into a summer, similarly shorn of celebrations. Given this, I have tended to use the camera mainly for landscape photography. Thankfully, this is a discipline where its new features are particularly useful.

Side Fall At bear Creek
Side Fall at Bear Creek (Fujifilm X100V, TCL X100 II)

First and foremost is the new lens. My somewhat crude studio testing against the previous “F” model back in March did suggest that close up and wide open the lens is markedly superior to its predecessor. I captured a lot of close-up, open aperture images mindful that I might need examples for such an article. I love the sharpness and bokeh of the optics though I was hardly offended by the previous version.

Spring in the Nescopeck Plain
Spring in the Nescopeck Plain (Fujifilm X 100V TCL X100 II)

The “V” model addition of weather sealing too is obviously useful in outdoor photography. Though I never worried too much about moisture affecting the previous versions, on a rainy day I would reach for my X Pro 2 with one of the weather-sealed primes. Now either with a UV filter or a lens converter (I use the TCL X100 all the time), I no longer have to worry for instance, about the spray from a waterfall when the camera is mounted to a tripod.

In the Sun (Fujifilm X100V, TLC X100 II)

Speaking of tripods, the flip-out screen has turned out to be very useful. I do have to occasionally remind myself that it’s available given the clean look of the camera, but for low-level tripod work, it is proven to be invaluable. I know that I will enjoy it when I go back to shooting on “the street” but for now is still very helpful.

Mid August Stream
Mid August Stream ( Fujifilm X100V)

I honestly have little negative to report in my months of usage. There is this odd effect I noticed when the cameras turned on and I take off the lens cap. In the viewfinder, the view is entirely washed out and takes time apparently for the camera metering to throttle back on the sensitivity/aperture. This happens consistently with this camera, but I have not noted on earlier Fujifilm products. I’m not sure what it means but it’s a minimal problem once the sensor adapts.

Late Fall Water Colors (Fujifilm X100V)

Another useful feature has been the Bluetooth connection between the camera and my phone. This is much less fussy in my use than the Wi-Fi connection, and give you a quick way to remotely release the camera and avoid camera shake. It appears to use very little battery life.

It’s a measure of my enjoyment of the camera that I have used it almost exclusively throughout the year. I store my raw images on two external hard drives using the function in Adobe Bridge to clear my memory cards. They are stored in the main folder for the year, and then subfolders for each camera and date span. I was actually downloading some files from another camera when I noted that almost all of the subfolders for the year are those from the X 100 V. There are none for the X Pro 2. Perhaps it’s time for a sale?

Last Bit of Autumn ( Fujifilm X100V)

In summary, the X 100 V has proven to be an excellent update of this wonderful camera line, one which I continue to use with great enthusiasm and I think with excellent results. Having a hard time imagining what the next version might bring to the table. I suspect image stabilization could be on the menu as Fujifilm seems to be packaging this feature into smaller and smaller bodies.

That would be wonderful… but I’m in no hurry

As always , I’d be honored if you would share this post.

Another Viral Post, October 1st

We are now in week 29 of what is apparently an endless state of behavior control by our omnipotent masters: the executive branch of Pennsylvania government. Once again, another legislative effort to loosen up the restrictions, in this case on the restaurant industry, has been vetoed by the governor. This is despite the fact that while we are seeing modest numbers of positive PCR tests, there is very little actual illness resulting.

I remind myself that when I posted my first “viral” article back in mid-March, I assume naïvely that this topic would die out by midsummer. That my cover image for this edition now features autumn foliage, is quite discouraging.

Meanwhile, our governor, in a conversation with Rep. Wendy Ullman of Bucks County, is caught on an open mike discussing the concept that for our elected elites, wearing masks in public is “political theatre”. Good to know.

In Pennsylvania, the small peak of cases we had over the summer is waning. The number of hospitalizations, ventilated patients are all decreasing from already modest levels and the percentage of emergency room visits devoted to COVID-like symptoms is well below 1%.

I think we know this anecdotally. Other than a few patients whom I have attended, I know perhaps 3 people who tested positive for this illness. One of them had a fairly severe flu-like illness from which she recovered. Another had a short period of mild respiratory symptoms. The third was absolutely asymptomatic and was retested in 4-5 days and found to be negative. Most people I talk to have similar impressions. I understand that I didn’t live or work in NYC or similar hotspots. I’m referring to Pa. and I think, most of the rest of the country.

One of the things I have been pondering about is the disparity I have noted between my liberal and conservative friends, and their attitude towards the pandemic. In general, my liberal friends tend to be much more concerned about the possibility of contracting the illness and are much more careful about human contact. My more conservative friends seem more willing to interact, and in general, are more casual about their behavior. In my mind, this crosses all intelligence levels in both political persuasions. While this disparity is not absolute, to me it seems pretty consistent.

Let me say that I am excluding from this discussion the more militant “anti-maskers” from this as #1 I don’t know anyone who is a complete nonconformist to the rules, and #2 given their lack of courtesy, I would tend to discount their opinions.

I don’t see anything innate in one’s political leanings that should lead to this effect. I refuse to believe for instance, that all my liberal friends, want to keep us shut down to affect the upcoming elections.

 I am left to believe that it is the media that we consume that forms our attitudes. It is clear to me that conservative media is more willing to entertain a certain skeptical approach to the pandemic through their pundits. The liberal media tends to emphasize the case numbers and the strains on the healthcare system where they occur. If there is a political motivation for this, I think it exists within the media and their allies in the political parties. This is a potentially dangerous game as it inhibits a purely rational approach to this outbreak.

So I shall once again restate my current thinking.  Yes, there is/was a pandemic. Each of the states has had different peaks depending on travel patterns and other factors. There has been an “excess of deaths” throughout the country, though the numbers don’t precisely match the COVID death numbers. There is a reasonable case to be made that some of the additional deaths may be consequences of the lockdown, particularly suicides, addiction, and the fear of hospitals by people who required medical attention.

Currently, I believe that per a number of sources including the New York Times article, that PCR testing is oversensitive and maybe creating a lot of false positive “cases”. I believe that rather than worry about the numbers of additional positive tests, we should scale our precautions based on actual disease burden which for now is modest at best.

I look at the pandemic the way I would look at a critically ill patient during my years as an intensivist. Let’s say a patient is admitted to the intensive care unit, with sepsis and low blood pressure. We would intervene in this, often by giving a large amount of IV fluid, plus drugs that can compress the blood vessels, raising the pressure. These modalities though, have long-term side effects that can be life-threatening, so in these situations, we are constantly testing. If the patient’s blood pressure appears to stabilize, we begin to withdraw the interventions. If the patient deteriorates then we may need to re-increase the therapy, but ultimately the goal is to discontinue these measures before they do the patient more harm.

This experience informs my attitude towards the current status of COVID in most of the country. The measures we took back in March, were certainly appropriate then, but they have been continued in situations where the “patient” seems to have stabilized. The problem is that prolonged intervention has done a lot of damage to large and small businesses that are now either crippled or deceased.

The goal of therapy needs to be the return of the “patient” to normal life as soon as possible. I suspect we would be doing this more aggressively if governor Wolf was not a “lame duck”, and if a presidential election were not imminent.

It’s now Autumn. Time to end the political theatre.

As always, we would be honored if you would share.

Header Image : Scene Along Glenside Road (Fujifilm X100V)

Viral Post, June 13

Farmstead Trail in June (Fujifilm X100V)

We are now in week 12 of the Wolfe/Levine coronavirus religious and economic lockdown. Most of the eastern portion of Pennsylvania is now in “yellow phase”. This does allow more businesses to open. It includes the so-called nonessential merchants, as well as bar/restaurants, the latter so long as they have an outdoor deck. “Personal-care” businesses such as barbers and hairstylists are still closed.

We found out yesterday that on June 19th, Luzerne County will be permitted to move into “green” phase. As great as it sounds, the rules for this phase are still very restrictive. I guess we should be grateful our benevolent overlords will permit us a little bit more of our rights.

Looking back on the previous weeks, I’m still puzzled by the whole question of nonessential businesses. Wouldn’t it have been smarter, for instance, to allow more retailers to stay open which would have the effect of spreading the pool of shoppers over a larger number of businesses?

Not that anyone cares about this in the governor’s office, but also wouldn’t that have been fairer?

Now that we are opening up, it would’ve been easy to rationalize some of the unusual precautions required by the new rules, such as temperature taking greeters, and mask-wearing waitresses. Hell, we’re all just glad to be out.

But then there was the vision of our governor, admittedly masked, but standing shoulder to shoulder with others in a large demonstration in Harrisburg (Dauphin County “yellow phase” no gatherings larger than 25 people). We watched as the ultimate zealot of pandemic propriety flouted the rules that he imposes on us non-protesters. No matter how worthy the cause, Mr. Wolf’s actions were hypocritical in the extreme. Kind of makes the “6-foot rule” feel silly doesn’t it? Remember, this is the man who called people protesting the unconstitutional lockdown “cowards”?

Want to protest and maybe do a little vandalism and looting? Apparently, it’s OK. Want to worship? Not so much.

 Almost as perverse was watching our health secretary, Dr. Levine using pretzel-like logic to justify the governor’s behavior.  Does anyone now doubt that the prolongation of the restrictions was purely political?

I don’t.

A couple of thoughts on the virus itself:

First, the WHO keeps changing its opinion as to whether asymptomatic people are likely to pass the infection on to others. First, they claimed that this is unlikely. Then they kinda backtracked. If the former is true, it suggests that taking one’s temperature on entering a business makes some sense, and there are technologies evolving that will allow us to do this automatically.

I do wonder however whether we should revert to the original CDC recommendations for facial coverings (only for patients known to have COVID 19, and their caregivers). I have certainly noticed as time goes on the people are getting more and more cavalier about masks, and I suspect their use will continue to decline.

The numbers of cases are certainly coming down. As I write this our local paper reports that there are no new cases in Luzerne County in the last 24 hours. This is likely the first time this is been true since mid-March.

When you look at the graphical data there is a clear decline since about mid-April. From March 15 to last Friday when we went into “yellow” phase, our county’s precautions have been in a steady state. If the virus had a constant level of infectivity, the curve should’ve leveled off at a roughly steady rate of increased cases/day, instead of steadily dropping as it has. To me, the continual decline suggests that something else is at work. it might be that the hoped-for warm weather decrease in the virus’s infectivity or virulence is real. Let’s hope this is the case.

There is talk of bumps in infection numbers in Texas and Arizona that some will blame on reopening. The infection rates in those communities are still very low and likely explained by significant increases in testing volume over time.

Though I am hopeful, I have no illusions. There is still COVID 19 in the environment, and if the wrong person ingests a significant amount of virus, then they may get sick and even possibly die. It will be some time for instance before I encourage my 94-year-old father to go out in public. It does not appear however that the average young or middle-age worker, or customer is at much risk. As long as the vulnerable are protected, we need commerce to resume.

I will be glad when we are finally allowed a more normal way of life.

Unless of course, our governor and his protesting friends cause another bump.

Who’s the “coward” now?

Thoughts on the Fujifilm X Pro 3

Maples (Fujifilm X Pro 2, XF 90mm f2,0)

I love buying new camera gear.  It is a wonderful pleasure to unbox an instrument that will help to facilitate new opportunities in photography.  Increasingly, however, it is difficult to improve upon current levels of technology, which even in modestly priced camera equipment, allows users to capture beautiful imagery in a wide range of settings.

Fujifilm recently teased the imminent release of the X Pro 3, the third version of their now-iconic range finder style camera.  As I have owned and used both of the previous X Pro versions, I was eager to see what improvements Fujifilm might have in store to tempt me into the newest product.  The details that have been released, leave me and with more questions than answers.

X Pro 2 ( Fujifilm image)

We know some details about the camera.  We know that rather than a body made from magnesium, the X Pro 3’s structure is fashioned from titanium, which is stronger, lighter, and more damage-resistant than previous bodies.

There are several new finishes available on the camera which also enhance the resistance to scratches and scuffs.

There is, as almost always with a new release, an improvement to the hybrid viewfinder which is been a signature feature of this line.  Apparently, the electronic viewfinder has a higher resolution, likely a faster refresh rate, and more sophisticated color reproduction.

It appears that the four-way controller on the X Pro 2 has been eliminated, as Fujifilm has done with several earlier releases.  I find for instance, on my XE3, that the joystick is a perfectly reasonable substitute.

Most significantly, we have an unusual change to the rear LCD.  There are actually two rear LCDs now.  The one on the back of the camera is a compact LCD similar to those seen on the top panel of the medium format cameras, as well as the XH 1.  This is mainly to show things like camera settings up.  It can also be set up to display what would have been in the past the end panel of a film box appropriate to the film simulation one has selected.  This will certainly bring back memories to those of us who shot in the film era. 

Fujifilm X Pro 3 (Fujifilm image)

The actual view screen is hidden in normal use but can be accessed as a hinged panel which one folds down allowing for waist-level photography.  It does not otherwise articulate, however.

Fujifilm X Pro 3 (Fujifilm image)

What up has not yet been revealed are details about things like Autofocus, video capability, and the sensor though the latter is presumed to be the 28-megapixel Trans X sensor found in the XT3.  At least in that camera, the sensor was not a clear improvement over the previous 24-megapixel sensor, particularly in aspects such as high ISO capability for resolution.

Again were lacking a lot of detail here, but once again I find myself thinking that this upgraded model does not feel like a compelling purchase.

First off, I tend to use the X Pro cameras for weddings and other event photography.  The current body has never felt particularly heavy or burdensome, in fact, it has a very solid well-built feel that perhaps would be lost if the titanium version weighs significantly less.  Also, titanium is quite expensive. Just what will this mean for the retail price of the X Pro 3 remains to be seen.

Monarch (Fujifilm XE3, XF 55-200mm f3.5-5)

The rear LCD arrangement I think is a lost opportunity.  I actually like the idea of the compact LCD display new camera settings, and sentimentally, the box label styled indicator of the film simulation.  This is apparently Fujifilm’s little manipulation to keep us looking through the viewfinder and to minimize “chimping”, emphasizing traditional photography. I’m not sure that’s any of their business.

In my camera cabinet, I have a relic of the past, a Panasonic GH1.  I keep it because it has an interesting color signature, and is capable of decent video.  It has my favorite rear LCD of all time, a viewfinder capable of either being displayed on the back of the camera, viewed from above or below, or even from the front of the camera. 

Panasonic GH1

I especially like that it can be folded so the rear viewfinder is against the camera body and protected from scratches.  To me, this style of viewfinder,  perhaps with the small LCD on the opposite side,  would have been a more interesting addition to the new camera It would allow users to work however they wished, rather than having their workflow dictated by Fujifilm.

This new design however, is not that disruptive to my usual workflow as I tend to shoot through the viewfinder. It will likely be a problem for other potential buyers.  It seems like an unforced error.

Fujifilm like everyone else struggles with the problem of upgrading current models that are already excellent.  We do not have all the details of this new camera, but so far I’m not sure I’m going to upgrade my X Pro 2 which is a joy to shoot and is capable of capturing beautiful imagery.

I’d like to be wrong, however. 

I hate to miss an unboxing.

The Gear That I Use: The Microsoft Surface Go Review

Mountain Laurel, Hickory Run (Fujifilm XE-3, XF 18-55 f2.8-4)

Recently, I made the decision to reduce my work hours, in the hopes of traveling more and indulging my other interests. I now have a benign, and more flexible work-life that I hope will allow me to continue to be happy and productive into my 70s.

Some of the travel I’ve been doing involves fairly short overnight trips to different parts of the region.  I like to pack light.  I generally take two camera bodies, one my X100 F , and an interchangeable lens Fuji like the XE-3, with several lenses.  All this fits into my Think Tank Retrospective 7 bag, which can also accommodate a 10-inch tablet.  The problem has been, finding the right tablet.    

As I have an aversion to anything Apple, I have relied on Android-based devices. Though usable, Android is not really compatible with Photoshop, or other photo editing programs that I generally use. It also can be cumbersome for general computing tasks. My ideal device seemed like a small (10-12 inch) Windows laptop for quick trips.

I learned perhaps 6 months ago, about the Windows Surface Go, a smaller version of the Windows Surface tablets that have been well received by the PC community. I promptly ordered one and have been using it for the last several months.

Surface Go with Keyboard (Microsoft Image)
Surface Go with Keyboard (Microsoft Image)

I’ve been exposed to the Microsoft Surface Line, through my computer engineer son who has been using one for several years.  They tend to be nicely designed and seem rather rugged.

The Surface G is similar in build quality with a sturdy metal body, and a very useful “kickstand” built into the device so that it can stand upright.  What I would call a mandatory option is the slick keyboard/cover which rather elegantly attaches by magnets to the tablet.  The overall package is slim and compact, more so for instance than my previous Asus tablet/keypad combinations.  I can carry it with all accessories, including a mouse and card reader, in a small tablet case.

Kickstand

It has a very nice touch pad screen though with a somewhat thick bezel, likely to facilitate holding without activating the screen.  It has a typical Surface magnetic charge port, a slot for the micro sd card,  and a USB C port, for connecting peripherals. It can also charge via USB which is rather handy.   

A nice touch is dual speakers on the wide axis of the device which sound surprisingly good.

Into my Camera bag

All of these features are nice, but as I’m processing Fujifilm raw files, processing power, as well as screen quality,   is rather important.

The Surface Go that I acquired is the higher performance of the two models.  It comes with an Intel Pentium Gold 4415Y processor, 8 GB of ram and 128 GB Of storage.  This is much less robust than the typical I series Intel chip in the bigger Surface devices. 

The tablet sports a 10 inch 1800X1200 touch screen, with a bit less resolution than the typical ipad of the same size.  Nonetheless, it is rather bright, and to my eye shows excellent detail.  I was able to color calibrate it rather easily. The tablet uses an Intel HD Graphics 615 card.

I am obviously not in the business of testing computer equipment, but the more professional reviews I read suggest that the overall the graphics performance of this computer along with the color gamut are well above average for inexpensive laptop type devices.

A welcome feature of the device is the “Windows Hello” which uses facial recognition to log you in. I wish my other computers would support this.

So how does it perform? I’ve installed a number of photo processing programs including Adobe Lightroom, Irident Transformer, and the free version of Capture One for Fujifilm. All of them run reasonably well but definitely slower than the i7 processors that run my big laptop and desktop computers.  Raw file conversion is a little slow but not obnoxious, and faster than on my previous Asus transformer (on which I could only run Photo mate).

This is not really a computer for editing bulk files or creating panoramas, but it works perfectly well to edit and preview individual images on the road. You will need to buy a USB C to USB 3 hub to use your card readers and other peripherals.

Jim Thorpe Summer Scene (Fujifilm XE-3, XF18-55mm f2.8-4)

Obviously, the small screen is less than optimal for running photo editing software, the obvious price for portability

It is really helpful to have a Windows-based computer that is so portable that it just isn’t a problem to stick it in your camera bag so you can review your files for instance at a breakfast restaurant after a morning in the field.

Flowers and Ferns ((Fujifilm XE-3, XF18-55mm f2.8-4)

One criticism of this device has been battery life.  Those people who test these devices professionally have noted that the battery life is somewhat below average for tablets.  There is some drain over time when the device is not in use, but overall I find it not a problem.  The included charger is rather small, fits easily in the bag, and quickly connects magnetically to the device.  The USB C port means I can even charge the device in my car as I drive from location to location.  I have noted however that you need a fairly high current charger to replenish the battery.

Doe and Fawns ((Fujifilm XE-3, XF18-55mm f2.8-4)

Overall, I’m very pleased with the Surface Go. Sure its screen is small, and you have to remember to keep it charged. Nevertheless, it feels like a full-featured Windows PC that I can open on a bar or a lunch counter and not feel awkward.

Pretty much, what I’ve been looking for.

Another Fujifilm Raw File Conversion Post, 2019 Edition… Addendum

Stubble
Stubble (Fujifilm X Pro 1, XF 60mm f2.4)

So it seems I was wrong (hardly an unusual situation).

Shortly after I wrote the last article, I noted on the Fuji Rumors site that the Silkipix-based imaging software, which has been the traditional free offering for Fujifilm, not only still exists, but has had an upgrade to handle the X-T30.

This confuses me.  I’m not sure why two companies, particularly Phase One, the developers of Capture One, who competes with Fujifilm in medium format, would offer free software to Fujifilm users.  Nonetheless, both are available.

It’s possible that Phase One feels that if Fuji users are exposed to its raw conversion benefits, they will opt for the full package, rather than continue with Adobe.

Fujifilm Raw Converter EX 3.0, like its previous versions, converts X-Trans files very nicely, on a par with the better offerings from other companies.  It’s just always seemed inconvenient, mainly because the workflow for most of us who use either Adobe or other more popular products, up has always seemed somewhat counterintuitive.  If I were a new Fujifilm owner, who wishes to shoot raw, but has not yet invested in one of the expensive software solutions, Capture One Express, and/or the Fujifilm Raw File Converter both work very well, once you become accustomed to them.

For many people, particularly the people that aren’t yet working in layers/masks, they could be all the software that you need.